Novel peptide antigens complexed with human leukocyte antigen (HLA) and ␤2-microglobulin (␤2M) molecules are presented at the cell surface to cytotoxic T lymphocytes (CTLs), provoking lysis of the antigenpresenting cell [ 
the frequency of ␤ 2 M mutations. Nine ␤ 2 M mutations were detected among 147 colorectal tumour biopsies. In contrast, only one of 133 non-colorectal tumours was found to contain a ␤ 2 M mutation. Thus, among the tumours we analyzed, ␤ 2 M mutations were significantly (p < 0.02) overrepresented in the colorectal carcinomas.
The ␤ 2 M mutations were identified by isolating and sequencing the PCR products ( Table 2 ). In the colorectal carcinomas, six mutations were in the sequence encoding the leader peptide of ␤ 2 M, two were located in exon 2 and one tumour (C43) contained a point mutation in the base immediately preceding the ATG initiation codon. The mutation in the only non-colorectal tumour, a lymphoma, was localized to exon 1 but was not further identified. Five of the ␤ 2 M mutations in the colorectal tumours were frameshifts at repeated elements. Overrepresented among these (three of nine) were 2 base-pair (bp) deletions in an 8 bp (CT) 4 repeat in the sequence encoding the leader peptide. A similar mutation is found at high frequency in some colorectal-carcinoma-derived cell lines [7, 8] . Tumour StM78 contained a minus (TG) frameshift at a (TG) 2 repeat in the leader peptide sequence. The mutation in exon 2 of StM185 was also in a repeated region; in this case, the mutation was a frameshift resulting from loss of an A from (A) 5 . These mutations introduce a termination signal 46 and 34 codons downstream, respectively.
In all DNA samples, both the wild-type and mutated ␤ 2 M alleles were present. This may indicate heterozygosity for ␤ 2 M mutations or might reflect contamination with normal tissue. Seven of the nine mutated tumours were examined PCR (polymerase chain reaction) and SSCP analysis of the ␤2M gene was performed as described previously using primers derived from the intronic sequences [7] .
by immunocytochemistry with antibodies W6/32 (directed against the ␤ 2 M-HLA A,B,C complex) and BBM.1 (directed against ␤ 2 M). In all cases, the expression of ␤ 2 M was reduced in comparison to that in adjacent normal stromal cells and lymphocytes. In three cases, ␤ 2 M expression was undetectable ( Table 2 ), suggesting that these tumours were not heterozygous for the ␤ 2 M mutations. Contaminating DNA from normal tissue surrounding the tumour, or from regions of tumour with normal ␤ 2 M, are the obvious source of wild-type DNA in the tumour samples that lacked detectable ␤ 2 M.
Microsatellite instability can be used to detect defects in DNA mismatch repair. DNA from 71 colorectal tumours was analyzed at three or more CA repeat microsatellite markers. For 37 of these samples, DNA from adjacent uninvolved epithelium was analyzed in parallel. Seven of the 71 tumour DNA samples (10 %) showed evidence of alterations at two or more microsatellite loci and were considered to exhibit microsatellite instability. No instability was detected among the normal DNA samples (< 3 %). These observations are in agreement with published values of around 10-15 % for the frequency of microsatellite instability in sporadic colorectal carcinomas [9] and indicate that our panel of colorectal carcinomas is representative in this respect. Instability was observed in five of nine samples with ␤ 2 M mutations. These included tumours that were homozygous or hemizygous for ␤ 2 M loss, as well as apparent heterozygotes in which ␤ 2 M expression was considerably reduced (Table 2) . Mismatch repair defects are therefore significantly more common amongst tumours with ␤ 2 M mutations (5/9) than in colorectal carcinomas in general (p < 0.01). These data are in agreement with our preliminary observations that ␤ 2 M mutations are more common in mismatch-repair-defective colorectal cell lines [8] . Microsatellite instability is found infrequently in the tumour types that made up most of the non-colon carcinomas in our study -breast ( [10] and R. Tan, P.K. and A.L. Harris, data not shown) and melanoma [11] . This is consistent with our finding of a lower frequency of ␤ 2 M mutations among these tumours than in the colorectal carcinomas.
An increased mutation rate alone is unlikely to account for the observed frequency of ␤ 2 M mutations in mismatch repair-defective colorectal tumours. Four tumors with ␤ 2 M mutations did not exhibit microsatellite instability ( Table 2 ). The high frequency of ␤ 2 M mutations among tumours with a normal spontaneous mutation rate implies that a second factor contributes to the emergence of . Staining was performed using alkaline phosphatase as previously described [19] . Frozen tissue sections (5 m thick) were fixed in cold acetone for 10 min at room temperature and air-dried overnight. Primary antibody was added to the dry sections in a humidified chamber for 30 min. Anti-mouse immunoglobin G (DAKO Z259) and APAAP complex (DAKO D651), both diluted 1:50 in Tris-buffered saline (TBS), were added sequentially (separated by a TBS washing period of 5 min). Incubation with the sections was for 30 min in each case. These steps were repeated to enhance the intensity of the final staining. After washing with TBS, the alkaline phosphatase substrate was then added for 15 min. Sections were counterstained with haematoxylin and mounted in an aqueous mounting medium. Tumour cell expression was determined by comparing the intensity of staining to that of lymphocytes and surrounding stromal cells. † Four loci containing dinucleotide repeat sequences on different chromosomes were analyzed. These loci were D2S123 (chromosome 2), D10S209 and AFMb001 (chromosome 10) and D17S941 (chromosome 17). In some cases, instability was confirmed by further analysis of the D13S175, D2S378, D2S119, D10S197 and D17S941 loci. Primer sequences have been published elsewhere [20] and were used in standard PCR reactions containing 50 mM KCl, 10 mM Tris-HCl (pH 8. tumours with ␤ 2 M mutations. In all cases we examined, the mutation was associated with a significant reduction in ␤ 2 M expression. The selective advantage gained by the consequent loss of ability to present HLA-associated antigen is therefore the most likely contributary factor. The high frequency with which acquired resistance to immunotherapy by CD8 + T cells is associated with loss of ␤ 2 M expression in melanoma [12] is evidence of the selective power of the immune system. Defects in mismatch repair would therefore be expected to influence the emergence of ␤ 2 M-defective tumours in two ways. First, repair-defective cells accumulate frameshift mutations in expressed genes [13, 14] and consequently synthesize many altered peptides. More vigorous CTL responses against repair-deficient tumours might thereby provide a heightened selective pressure for loss, or reduction, of surface antigen presentation [15] . Second, the reiterated sequences in the ␤ 2 M gene represent 'hotspots' for inactivating frameshifts in a repair-deficient background. These two factors provide a ready explanation for the preponderance of ␤ 2 M mutations in tumour cells defective in mismatch repair.
An independent example of the overrepresentation of a particular mutation -as a consequence of a mutator phenotype combined with a selective pressure -is provided by the loss of responsiveness of colorectal carcinomas to transforming growth factor-␤ (TGF-␤) [16] . Frameshifts in repeated sequences within the TGF-␤ receptor type II gene are frequently associated with inactivation of the TGF-␤ receptor in colon tumours with microsatellite instability. Endometrial tumours are not normally responsive to TGF-␤, and TGF-␤ receptor mutations are not found in endometrial tumours with microsatellite instability [17] . Thus, the acquisition of a mutation in an identifiable hotspot and selective pressure are both required for the emergence of tumours with the altered genotype.
Loss of ␤ 2 M expression has profound effects on peptide presentation because ␤ 2 M is required for antigen presentation by all class I HLA molecules (HLA-A, HLA-B and HLA-C). Our data indicate that loss or reduction of ␤ 2 M expression can arise through mutation in the ␤ 2 M gene, and that this event is particularly likely in colorectal tumours with defects in mismatch repair. This, together with the increased susceptibility of such repair-defective cells to elimination by CTLs, provides a mechanistic explanation for the association between microsatellite instability and ␤ 2 M gene mutations in colorectal tumours.
